Production of T 3 from T 4 in tissues is catalyzed by two 5Ј-deiodinases, type I (D1) and type II (D2), but the quantitative contribution of each pathway to whole body T 3 production is not well established. In the presence of propylthiouracil (PTU), D1, but not D2, can be effectively blocked, providing an experimental probe for addressing this problem. Decades ago, this approach provided indirect estimates ranging from 23-44% contribution by D2, based on plasma T 3 appearance rate comparisons (PAR 3 ϭ PCR 3 [T 3 ] p ) in periodically T 4 -injected athyreotic rats vs. controls. Two, more recent studies, using constant infusions of T 4 for replacement, achieved 22% and 65% estimates, respectively, from PAR 3 comparisons. We have revisited this problem more directly and precisely, with two major differences in experiment design. We used direct whole body steady state measurements of T 3 production, instead of indirect plasma-only data (PAR 3 ). We also used (euthyroid) physiological doses of both T 4 (0.9 g/day⅐100 g BW) and T 3 (0.15 g/day⅐100 g BW) for replacement in two thyroidectomized rat groups, instead of T 4 only, in a 7-day constant steady state, dual tracer infusion protocol. The first group also had chronically implanted 150-mg PTU pellets (TXR-PTU); the other had implanted 0.1 N NaOH placebo pellets (TXR-EU); each delivered their product at constant rates. A third euthyroid intact group was used as the controls. The completeness of D1 inhibition was ascertained in a fourth group, identically treated with 150-mg PTU pellets, in which negligible D1 activity was found in liver and kidney using labeled rT 3 as substrate for the 5Ј-D assays and minimal (1 mM) dithiothreitol as cofactor. In the TXR-PTU group, the percentage of T 4 converted to T 3 was 11.8%, compared with 23.4% (P Ͻ 0.0005) in the TXR-EU group, and 22.7% (P ϭ NS) in controls. Thus, in euthyroid steady state, D2 contributes about half of the T 3 produced from T 4 . (Endocrinology 139: 4626 -4633, 1998) I T IS NOW well established that T 3 production from T 4 is locally regulated and catalyzed by at least two tissuespecific 5Ј-deiodinase enzymes, type I (D1) and type II (D2), distinguishable by several factors. D1 is highly sensitive to inhibition by 6-propyl-2-thiouracil (PTU) and other thiols (1), with a K m in the nanomolar range with physiological cofactors such as glutathione (2), and its affinity is higher for rT 3 than for T 4 (1). D1 is expressed in many tissues, but the highest levels are found in liver, kidney, and thyroid in humans and rodents (3). In contrast, D2 is relatively insensitive to PTU, it also has a K m in the nanomolar range, and its affinity is higher for T 4 than for rT 3 (1). In rodents, D2 is expressed primarily in the central nervous system, anterior pituitary, and brown adipose tissue (4 -6) and in humans in the central nervous system (7), placenta, skeletal muscle, heart, and thyroid (8 -10).D1 and D2 activities are strongly correlated with thyroid hormone status. D2 activity is increased in hypothyro...